| Filed | Form | Description | |
|---|---|---|---|
| 4/28/23 | F-3 | F-3 | → |
| 10/15/19 | F-3 | F-3 | → |
| 2/14/19 | 424B3 | 424B3 | → |
| 1/14/19 | F-3 | F-3 | → |
| 12/19/18 | 424B5 | 424B5 | → |
| 10/19/17 | F-3 | F-3 | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 11/12/24 | SC 13G/A | SC 13G/A | → |
| 2/9/24 | SC 13G/A | SC 13G/A | → |
| 2/9/23 | SC 13G/A | SC 13G/A | → |
| 2/9/22 | SC 13G | SC 13G | → |
| 2/11/21 | SC 13G/A | AMENDMENT TO FORM SC 13G | → |
| 2/14/20 | SC 13G/A | AMENDMENT TO FORM SC 13G | → |
| ↓ | |||
| Filed | Form | Description | |
|---|---|---|---|
| 5/5/23 | EFFECT | EFFECT | → |
| 10/30/19 | EFFECT | EFFECT | → |
| 7/30/19 | D | D | → |
| 2/12/19 | EFFECT | EFFECT | → |
| 12/21/18 | D | D | → |
| 11/16/18 | CT ORDER | CT ORDER | → |
| ↓ | |||
Immutep Ltd is a biotechnology company working primarily in the field of cancer immunotherapy using the LAG3 immune control mechanism. The company was originally built on CVac, a therapeutic cancer vaccine.